Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
25 oct. 2018 08h30 HE
|
Scythian Biosciences Corp.
TORONTO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has changed its...
Scythian Biosciences Makes Strategic Investment in Verano™ Holdings with $188 Million USD Transaction
23 oct. 2018 07h00 HE
|
Scythian Biosciences Corp.
Scythian Invests USD$88 Million in Verano Class B Membership Units Scythian to Sell 3 Boys Farms in Share Exchange for USD$100 Million in Verano Class B Membership Units M&A Identified, Talent...
Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis
12 oct. 2018 08h15 HE
|
Scythian Biosciences Corp.
Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in...
Scythian Biosciences Announces Major Milestone in U.S. Expansion
11 oct. 2018 08h15 HE
|
Scythian Biosciences Corp.
Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida 3 Boys Farms Gets...
Scythian Biosciences Appoints Brady Cobb as CEO
03 oct. 2018 08h41 HE
|
Scythian Biosciences Corp.
TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today Brady Cobb, a leading voice...
Scythian Biosciences Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
01 oct. 2018 08h00 HE
|
Scythian Biosciences Corp.
TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (“Scythian” or the “Company”) (CSE:SCYB) (Frankfurt: 9SB) (OTC – Nasdaq Intl: SCCYF) announced its intention to commence a...
Scythian Biosciences Appoints Peter Liabotis as CFO
28 sept. 2018 08h32 HE
|
Scythian Biosciences Corp.
TORONTO, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Peter Liabotis, a veteran senior corporate finance executive and certified public accountant, has been appointed Chief Financial Officer of Scythian...
Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets
27 sept. 2018 12h02 HE
|
Scythian Biosciences Corp.
Scythian Received 15,678,310 common shares of Aphria Inc. as Consideration for the Sale Scythian’s Current Number of Issued and Outstanding Common Shares is 48,849,218 TORONTO, Sept. 27, 2018 ...
Scythian Biosciences Closes Acquisition of MMJ International Investments Inc.
21 sept. 2018 08h00 HE
|
Scythian Biosciences Corp.
Closing of Argentine Acquisition is Key Benchmark in Finalization of Previously Announced $193 Million Sale of Assets in Latin America, Which as of Prior Day Close was Valued At Approximately $313...
Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders
17 sept. 2018 08h00 HE
|
Scythian Biosciences Corp.
Shareholders Approve Strategic Sale of Latin American Assets to Aphria in Exchange for 15,678,310 shares of Aphria (TSX:APH) Shareholders Approve Name Change to SOL Investments Corp. Scythian’s...